Nucleic Acids Research, 2000, Vol. 28, No. 12 2420-2430
© 2000 Oxford University Press
Potent inhibition of Werner and Bloom helicases by DNA minor groove binding drugs
Laboratory of Molecular Genetics, Box 1, National Institute on Aging, GRC, NIH, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA and 1Imperial Cancer Research Fund Laboratories, Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK
Maintenance of genomic integrity is vital to all organisms. A number of human genetic disorders, including Werner Syndrome, Bloom Syndrome and Rothmund–Thomson Syndrome, exhibit genomic instability with some phenotypic characteristics of premature aging and cancer predisposition. Presumably the aberrant cellular and clinical phenotypes in these disorders arise from defects in important DNA metabolic pathways such as replication, recombination or repair. These syndromes are all characterized by defects in a member of the RecQ family of DNA helicases. To obtain a better understanding of how these enzymes function in DNA metabolic pathways that directly influence chromosomal integrity, we have examined the effects of non-covalent DNA modifications on the catalytic activities of purified Werner (WRN) and Bloom (BLM) DNA helicases. A panel of DNA-binding ligands displaying unique properties for interacting with double helical DNA was tested for their effects on the unwinding activity of WRN and BLM helicases on a partial duplex DNA substrate. The levels of inhibition by a number of these compounds were distinct from previously reported values for viral, prokaryotic and eukaryotic helicases. The results demonstrate that BLM and WRN proteins exhibit similar sensitivity profiles to these DNA-binding ligands and are most potently inhibited by the structurally related minor groove binders distamycin A and netropsin (Ki 
1 µM). The distinct inhibition of WRN and BLM helicases by the minor groove binders suggest that these helicases unwind double-stranded DNA by a related mechanism.
* To whom correspondence should be addressed. Tel: +1 410 558 8162; Fax: +1 410 558 8157; Email: vbohr@nih.gov
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Ghosh, M. L. Rossi, J. Aulds, D. Croteau, and V. A. Bohr Telomeric D-loops Containing 8-Oxo-2'-deoxyguanosine Are Preferred Substrates for Werner and Bloom Syndrome Helicases and Are Bound by POT1 J. Biol. Chem., November 6, 2009; 284(45): 31074 - 31084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Panchal, R. L. Ulrich, D. Lane, M. M. Butler, C. Houseweart, T. Opperman, J. D. Williams, N. P. Peet, D. T. Moir, T. Nguyen, et al. Novel Broad-Spectrum Bis-(Imidazolinylindole) Derivatives with Potent Antibacterial Activities against Antibiotic-Resistant Strains Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4283 - 4291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zhang, A.-h. Zhang, L. Chen, and X. G. Xi Inhibition of DNA Helicase, ATPase and DNA-Binding Activities of E. coli RecQ Helicase by Chemotherapeutic Agents J. Biochem., June 1, 2008; 143(6): 773 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Choudhary, K. M. Doherty, C. J. Handy, J. M. Sayer, H. Yagi, D. M. Jerina, and R. M. Brosh Jr. Inhibition of Werner Syndrome Helicase Activity by Benzo[a]pyrene Diol Epoxide Adducts Can Be Overcome by Replication Protein A J. Biol. Chem., March 3, 2006; 281(9): 6000 - 6009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. von Kobbe, N. H. Thoma, B. K. Czyzewski, N. P. Pavletich, and V. A. Bohr Werner Syndrome Protein Contains Three Structure-specific DNA Binding Domains J. Biol. Chem., December 26, 2003; 278(52): 52997 - 53006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Driscoll, S. W. Matson, J. M. Sayer, H. Kroth, D. M. Jerina, and R. M. Brosh Jr. Inhibition of Werner Syndrome Helicase Activity by Benzo[c]phenanthrene Diol Epoxide dA Adducts in DNA Is Both Strand-and Stereoisomer-dependent J. Biol. Chem., October 17, 2003; 278(42): 41126 - 41135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. von Kobbe, P. Karmakar, L. Dawut, P. Opresko, X. Zeng, R. M. Brosh Jr., I. D. Hickson, and V. A. Bohr Colocalization, Physical, and Functional Interaction between Werner and Bloom Syndrome Proteins J. Biol. Chem., June 7, 2002; 277(24): 22035 - 22044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Machwe, L. Xiao, S. Theodore, and D. K. Orren DNase I Footprinting and Enhanced Exonuclease Function of the Bipartite Werner Syndrome Protein (WRN) Bound to Partially Melted Duplex DNA J. Biol. Chem., February 1, 2002; 277(6): 4492 - 4504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wu and N. Maizels Substrate-specific inhibition of RecQ helicase Nucleic Acids Res., April 15, 2001; 29(8): 1765 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mohaghegh and I. D. Hickson DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders Hum. Mol. Genet., April 1, 2001; 10(7): 741 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Brosh Jr., A. Majumdar, S. Desai, I. D. Hickson, V. A. Bohr, and M. M. Seidman Unwinding of a DNA Triple Helix by the Werner and Bloom Syndrome Helicases J. Biol. Chem., January 26, 2001; 276(5): 3024 - 3030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Villani and N. Tanguy Le Gac Interactions of DNA Helicases with Damaged DNA: Possible Biological Consequences J. Biol. Chem., October 20, 2000; 275(43): 33185 - 33188. [Full Text] [PDF]
|
|